阿克拉霉素治疗难治、复发性急性白血病的临床观察

The Treatment of Refractory and Relapsed Cases of Acute Leukemia with Aclacinomycin

应用含阿克拉霉素的联合化疗方案治疗难治性及复发性急性白血病23例。急淋11例(L_1 3例,L_2 6例,L_3 2例),急非淋12例(M_1 2例,M_2 4例,M_4 5例,M_5 1例)。完全缓解率56.6%,部分缓解率8.7%,总有效率65.3%。含阿克拉霉素的联合化疗方案对难治、复发性急性白血病具疗效高、副反应小的优点,是较理想的化疗方案。

In this paper 23 cases with refractory and relapsed acute leukemiareceived the combined chemotherapy of aclacinomycin. The results showed that thecomplete remission rate was 56.6%, partial remission was 8.7%, effetive rate was65.3%. This indicated that aclacinomycin is an efficacious drug for the treatment ofrefractory and relapsed acute leukemia.